/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-09-18-07-56-38-946-66ea87b6fd15f83eafe2012f.jpg)
Resolution 2,386/2024 of the CFM aims to regulate the physician-healthcare industry relationship by prioritizing a transparent and...
Cortex - Life Sciences Insights
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-09-13-08-00-32-527-66e3f1207b0e94b9f9480703.jpg)
Decoding the regulatory conundrum Biopharmaceutical companies are navigating an increasingly complex global regulatory landscape that...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-06-05-13-32-58-962-6660690a58341fc77b2f9c2d.jpg)
On 21 May 2024, the Medicines & Healthcare products Regulatory Agency (“MHRA”) issued a Statement of Policy Intent on International...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-05-15-09-38-35-761-6644829b4c6fd57c72b488aa.jpg)
On Wednesday May 8th 2024, the Belgian Parliament adopted a new law to combat the costs arising from the unavailability of medicinal...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-04-18-09-16-42-370-6620e4fa7330266071d4ac1d.jpg)
Impressive advancements in the pharma industry provide hope to patients affected by debilitating and life-threatening diseases and a...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-03-12-13-59-49-649-65f05fd5bd27a46ab25a5cfb.jpg)
DLA Piper's Life Sciences Regulatory team, led by Marco de Morpurgo, recently produced a Q&A guide to life sciences regulation in the EU...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-01-08-12-59-45-827-659bf1c1660cf964fb320221.jpg)
Since 2006, when the Medicines Code was approved in Portugal, marketing authorisation holders had to include the retail selling price of...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-12-21-09-26-53-656-658404dd39023fc6c238563c.jpg)
As the New Year is fast approaching, we asked members of our international Life Sciences team to share their predictions of what will be...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-11-23-10-33-01-676-655f2a5db70736404a7e7ede.jpg)
Executive Summary Combination therapies involve the use of two or more separate medicines in combination to treat a disease. It can be...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-05-29-16-50-42-903-6474d7e2473d2835c1506ef7.jpg)
On 23 May 2023, Joost Haans from our Life Sciences team attended the EU Pharma Law Forum in Brussels where he participated in the...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-05-26-07-18-24-466-64705d4090422089088ba1f3.jpg)
Exactly one month ago, on 26 April 2023, the European Commission (EC) adopted its long-awaited proposal for the revision of the EU...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-05-19-11-08-09-478-646758998d0df7e25a82844c.jpg)
On May 3rd of this year, Anvisa approved Resolution No. 786/2023 ("RDC 786/2023"), which addresses the technical and health requirements...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-04-28-12-17-26-839-644bb956474c4c94b77241db.jpg)
On the 1 April this year, amidst storm clouds gathering above the NHS in the form of staffing strikes, record waiting times and chronic...
As of March 28, The Italian Council of Ministers have approved the new Public Contracts Code. The Legislative Decree No. 36 of March 31,...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-04-04-13-42-31-249-642c2947f636ea14f4a21bdf.jpg)
Companies operating in the life sciences industry play a vital role in raising awareness of diseases and other medical conditions,...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-03-14-14-13-17-911-641080fdf636ea124826fb39.jpg)
Due to a complex array of legislation, regulations and codes, advertising therapeutic goods in compliance with Australian law can be a...
